ADC Therapeutics SA: ADC Therapeutics to Participate in May Investor Conferences
ADC Therapeutics SA: ADC Therapeutics to Participate in May Investor Conferences ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company leading the development of novel antibody drug conjugates (ADCs) to treat hematological malignancies and solid tumors, announced today that Chris Martin, Chief Executive Officer, will participate in a fireside chat at two virtual investor conferences in May. Details of the events are as follows: BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021, at 8:00 a.m. ET 2021 RBC Capital Markets Global Healthcare Conferenc...